STANFORD UNIVERSITY

STANFORD UNIVERSITY logo
🇺🇸United States
Ownership
Private
Established
1885-11-11
Employees
10K
Market Cap
-
Website
http://www.stanford.edu
seekingalpha.com
·

Summit Therapeutics Bests Merck's Top Selling Drug In Phase III Trial

Brendan, a Stanford Ph.D. in organic synthesis, worked at Merck and co-founded 1200 Pharma at Caltech. He remains an investor in biotech stocks. Analyst's disclosure: beneficial long position in SMMT shares. Disclaimer: SMMT is a high-risk, speculative, pre-revenue company.
biospace.com
·

New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30 ...

TG Therapeutics presented updated ENHANCE Phase 3b trial data on BRIUMVI® (ublituximab-xiiy) for relapsing forms of multiple sclerosis (RMS) at the 2024 ECTRIMS annual meeting, highlighting successful transition from prior anti-CD20 treatment and safe 30-minute infusions with mild reactions.
med.stanford.edu
·

Euan Ashley becomes chair of the Department of Medicine

Euan Ashley, MB ChB, DPhil, a cardiovascular and genetics research specialist, has been named chair of the Department of Medicine at Stanford, effective Sept. 18. Ashley founded the Stanford Center for Inherited Cardiovascular Disease and leads the Ashley Lab, focusing on precision medicine, digital health, and AI. He has over 350 peer-reviewed publications and received the Guggenheim Fellowship in 2023. Ashley aims to connect precision diagnostics with therapeutics in his new role.
cdc.gov
·

Board of Scientific Counselors: Members

The article profiles various professionals in health and statistics, including John R. Lumpkin, M.D., M.P.H., Mollyann Brodie, Ph.D., Kennon R. Copeland, Ph.D., Tara Das, Ph.D., M.P.H., M.L.I.S., Scott H. Holan, Ph.D., V. Joseph Hotz, Ph.D., Bradley Malin, Ph.D., Sally C. Morton, Ph.D., Lucila Ohno-Machado, M.D., M.B.A., Ph.D., Andy Peytchev, Ph.D., C. Matthew Snipp, Ph.D., Kelly Hoover Thompson, J.D., and David R. Williams, Ph.D., detailing their roles, achievements, and contributions to their respective fields.
psypost.org
·

AI could be the breakthrough that allows humanoid robots to jump from science fiction to reality

Humanoid robots, backed by AI, are advancing rapidly, with potential applications from factories to homes. AI-enabled 'brains' could improve interaction, giving robots an 'iPhone moment'. Ethical considerations and market viability are key challenges, with experts needed to navigate the technology's future.
drugs.com
·

Polluting Puff: Asthma Inhalers Are Big Contributors to Climate Change

Asthma inhalers contribute significantly to climate change due to potent greenhouse gas emissions, with metered-dose inhalers accounting for 98% of total emissions. Researchers suggest considering emissions when choosing inhalers, despite higher costs of alternatives.
dermatologytimes.com
·

Derm In The News: September 8-14

ZeroEyes' AI gun detection system implemented at Lane Dermatology, Sweden sees decline in melanoma among under-50s, study finds higher phthalate levels in young children using personal care products, Mary-Margaret Chren to retire from Vanderbilt and join Stanford, Medscape Education partners with Comprehensive Medical Mentoring Program to enhance dermatology diversity, NY Governor Kathy Hochul diagnosed with basal cell carcinoma.
theglobeandmail.com
·

'AI godmother' Fei-Fei Li raises US$230-million to launch AI startup

Fei-Fei Li raises $230 million for World Labs, an AI startup focusing on spatial intelligence to understand the 3D world, with investors including Andreessen Horowitz and Nvidia’s NVentures. Li, known as the 'godmother of AI,' aims to develop 'large world models' to enhance AI's reasoning capabilities, avoiding 'hallucinations' in rendering.

CoMotion, a champion for innovation at the UW, supports research by Valerie Daggett and ...

Valerie Daggett's journey from discovering her passion for proteins to founding AltPep, a company developing a blood test for Alzheimer’s, highlights the role of UW's CoMotion in supporting innovation and startups. CoMotion provides resources, training, and funding to bridge the gap between research and commercialization, aiming to scale lifesaving technologies globally.
© Copyright 2024. All Rights Reserved by MedPath